Search research articles
Contact Us
Filters
Showing results (31-40 of 132) with videos related to
Page
of 14
Sort By:
Antiviral Therapy
|
November 29, 2012
Antiviral resistance and direct-acting antiviral agents for HCV
Amanda L Aloia, Stephen Locarnini, Michael R Beard
Nature Reviews. Gastroenterology & Hepatology
|
February 25, 2016
Global strategies are required to cure and eliminate HBV infection
Peter Revill, Barbara Testoni, Stephen Locarnini, et al.
Journal of Medical Virology
|
November 11, 2020
Real-world application of the Xpert® HBV viral load assay on serum and dried blood spots
Kathy Jackson, Rosemary Tekoaua, Xin Li, et al.
The Lancet. Infectious Diseases
|
February 14, 2012
Selection of chronic hepatitis B therapy with high barrier to resistance
Robert Gish, Ji-Dong Jia, Stephen Locarnini, et al.
Seminars in Cancer Biology
|
September 10, 2013
Possible origins and evolution of the hepatitis B virus (HBV)
Stephen Locarnini, Margaret Littlejohn, Muhammad Nazri Aziz, et al.
Journal of Hepatology
|
April 29, 2015
Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugs
Stephen Locarnini, Angelos Hatzakis, Ding-Shinn Chen, et al.
Clinical and Vaccine Immunology : CVI
|
August 9, 2006
Reduced expression of toll-like receptor 2 on peripheral monocytes in patients with chronic hepatitis B
Stephen M Riordan, Narelle Skinner, Jelica Kurtovic, et al.
Journal of Medical Virology
|
April 13, 2019
Evaluation of dried blood spots for hepatitis B and D serology and nucleic acid testing
Kathy Jackson, Thomas Holgate, Rosemary Tekoaua, et al.
Antiviral Therapy
|
June 25, 2013
An update on HDV: virology, pathogenesis and treatment
Mónica V Alvarado-Mora, Stephen Locarnini, Mario Rizzetto, et al.
Journal of Medical Virology
|
December 2, 2009
Bioinformatic analysis of the hepadnavirus e-antigen and its precursor identifies remarkable sequence conservation in all orthohepadnaviruses
Peter Revill, Lilly Yuen, Renae Walsh, et al.
Page
of 14
Search research articles
Search
Showing results (31-40 of 132) with videos related to
Sort By:
Page
of 14
Antiviral Therapy
|
November 29, 2012
Antiviral resistance and direct-acting antiviral agents for HCV
Amanda L Aloia, Stephen Locarnini, Michael R Beard
Nature Reviews. Gastroenterology & Hepatology
|
February 25, 2016
Global strategies are required to cure and eliminate HBV infection
Peter Revill, Barbara Testoni, Stephen Locarnini, et al.
Journal of Medical Virology
|
November 11, 2020
Real-world application of the Xpert® HBV viral load assay on serum and dried blood spots
Kathy Jackson, Rosemary Tekoaua, Xin Li, et al.
The Lancet. Infectious Diseases
|
February 14, 2012
Selection of chronic hepatitis B therapy with high barrier to resistance
Robert Gish, Ji-Dong Jia, Stephen Locarnini, et al.
Seminars in Cancer Biology
|
September 10, 2013
Possible origins and evolution of the hepatitis B virus (HBV)
Stephen Locarnini, Margaret Littlejohn, Muhammad Nazri Aziz, et al.
Journal of Hepatology
|
April 29, 2015
Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugs
Stephen Locarnini, Angelos Hatzakis, Ding-Shinn Chen, et al.
Clinical and Vaccine Immunology : CVI
|
August 9, 2006
Reduced expression of toll-like receptor 2 on peripheral monocytes in patients with chronic hepatitis B
Stephen M Riordan, Narelle Skinner, Jelica Kurtovic, et al.
Journal of Medical Virology
|
April 13, 2019
Evaluation of dried blood spots for hepatitis B and D serology and nucleic acid testing
Kathy Jackson, Thomas Holgate, Rosemary Tekoaua, et al.
Antiviral Therapy
|
June 25, 2013
An update on HDV: virology, pathogenesis and treatment
Mónica V Alvarado-Mora, Stephen Locarnini, Mario Rizzetto, et al.
Journal of Medical Virology
|
December 2, 2009
Bioinformatic analysis of the hepadnavirus e-antigen and its precursor identifies remarkable sequence conservation in all orthohepadnaviruses
Peter Revill, Lilly Yuen, Renae Walsh, et al.
Page
of 14